Welcome to men2men, your one stop site for all you’ve ever wanted to know but were afraid to ask. This site will offer you concrete advice and up to date information on a wide range of topics to help you ensure your own health and wellbeing.
Sexual diversity has always been part of a normal society and there is no justification for attempts to eliminate people who are not heterosexual from society. Efforts should rather be focused on countering the stigmatisation that creates hostile and violent environments for those who are othered within heteronormative societies.
This is reiterated in a consensus report entitled Diversity in Human Sexuality: Implications for Policy in Africa released by the Academy of Science of South Africa (ASSAf) at a launch event coinciding with the 7th SA AIDS Conference in Durban.
Researchers have shown that a new experimental therapy can dramatically reduce the amount of HIV present in a patient’s blood.
The results stem from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, conducted by Rockefeller University researchers in New York.
The work, reported this week in Nature, brings fresh optimism to the field of HIV immunotherapy and suggests new strategies for fighting or even preventing HIV infection, they said.
Despite the rise in dating apps being associated with one time sexual encounters or ‘hooking up’, recent research from the Kirby Institute at the University of New South Wales in Australia has found that more gay and bisexual men are meeting their long term partners through online dating.
Researchers surveyed 4215 gay and bisexual Autralian men and found that almost 80 per cent of respondents had met their primary regular partner online. The results suggest that the use of online dating to meet sexual and romantic partners has largely displaced other methods of meeting partners.
British researchers have shown that pre-exposure prophylaxis (PrEP) is highly protective against HIV for gay and other men who have sex with men (MSM).
While ARVs are traditionally used to treat people who are HIV positive, certain ARVs can also be used to prevent HIV negative men from becoming infected, a method referred to as pre-exposure prophylaxis (PrEP).
In a remarkable new advance against the virus that causes AIDS, scientists from America’s The Scripps Research Institute (TSRI) have announced the creation of a novel drug candidate that is so potent and universally effective, it might be used as a new kind of vaccine.
Researchers at the University of Rochester Medical Center in the United States are testing a new oral vaccine to prevent infection with HIV, the virus that causes AIDS. The vaccine is unique because it is given as a pill, unlike most HIV vaccines tested to date that have been given as shots.